{"id":"https://openalex.org/W2185567445","doi":null,"title":"Erlotinib antitumor activity in non-small cell lung cancer models is independent of HER1 and HER2 overexpression.","display_name":"Erlotinib antitumor activity in non-small cell lung cancer models is independent of HER1 and HER2 overexpression.","publication_year":2006,"publication_date":"2006-09-01","ids":{"openalex":"https://openalex.org/W2185567445","mag":"2185567445","pmid":"https://pubmed.ncbi.nlm.nih.gov/17094474"},"language":"en","primary_location":{"id":"pmid:17094474","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17094474","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112474280","display_name":"Thomas Friess","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Friess","raw_affiliation_strings":["Roche Diagnostics GmbH, Pharma Research Penzberg, Department of Pharmacology TR-PD2, Nonnenwald 2, D-82372 Penzberg, Germany. thomas.friess@roche.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Diagnostics GmbH, Pharma Research Penzberg, Department of Pharmacology TR-PD2, Nonnenwald 2, D-82372 Penzberg, Germany. thomas.friess@roche.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073502196","display_name":"Werner Scheuer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Scheuer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057758171","display_name":"Max Hasmann","orcid":"https://orcid.org/0000-0002-6188-7843","observed_orcids":["https://orcid.org/0000-0002-6188-7843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Hasmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5839,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.83424771,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"5A","first_page":"3505","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.041600000113248825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8889999985694885},{"id":"https://openalex.org/keywords/tumor-markers","display_name":"tumor markers","score":0.5659999847412109},{"id":"https://openalex.org/keywords/serum-tumor-markers","display_name":"serum tumor markers","score":0.8659999966621399},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.722000002861023},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9851898550987244},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.7702997922897339},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6988346576690674},{"id":"https://openalex.org/C2909325608","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib Hydrochloride","level":5,"score":0.5962859988212585},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5377943515777588},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5333760976791382},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5234434008598328},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.455575168132782},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43477460741996765},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38328325748443604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.349187433719635}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:17094474","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17094474","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2185567445","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17094474","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W39200173","https://openalex.org/W1605302012","https://openalex.org/W1659692600","https://openalex.org/W1779286308","https://openalex.org/W1910732341","https://openalex.org/W1986092295","https://openalex.org/W1996141967","https://openalex.org/W1999828947","https://openalex.org/W2000692224","https://openalex.org/W2006709656","https://openalex.org/W2013545665","https://openalex.org/W2014718912","https://openalex.org/W2037150236","https://openalex.org/W2045728965","https://openalex.org/W2049239930","https://openalex.org/W2049484790","https://openalex.org/W2051120695","https://openalex.org/W2055217375","https://openalex.org/W2064047613","https://openalex.org/W2079574908","https://openalex.org/W2101055110","https://openalex.org/W2103134643","https://openalex.org/W2109823193","https://openalex.org/W2120819664","https://openalex.org/W2135422811","https://openalex.org/W2146428449","https://openalex.org/W2151220251","https://openalex.org/W2154100643","https://openalex.org/W2155152706","https://openalex.org/W2155180567","https://openalex.org/W2156394877","https://openalex.org/W2158179945","https://openalex.org/W2162724777","https://openalex.org/W2163252214","https://openalex.org/W2163402367","https://openalex.org/W2168258970","https://openalex.org/W2242848604","https://openalex.org/W2244156441","https://openalex.org/W2268190867","https://openalex.org/W2278057905","https://openalex.org/W2297901492","https://openalex.org/W2417534909","https://openalex.org/W2472568834","https://openalex.org/W2527882685","https://openalex.org/W2586622922","https://openalex.org/W2741190746"],"related_works":["https://openalex.org/W1966672421","https://openalex.org/W2154100643","https://openalex.org/W2164623396","https://openalex.org/W2152048090","https://openalex.org/W2092762795","https://openalex.org/W2116247728","https://openalex.org/W2115551968","https://openalex.org/W149878878","https://openalex.org/W1965850768","https://openalex.org/W1988028563"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,20,69],"human":[2],"epidermal":[3],"growth":[4,117],"factor":[5],"receptors":[6],"HER1/EGFR":[7,33,41,86,119,157],"and":[8,42,82,87,109,120,158],"HER2":[9,43,88,121,159],"offer":[10],"potential":[11],"targets":[12],"for":[13,66],"treating":[14],"non-small":[15],"cell":[16],"lung":[17],"cancer":[18],"(NSCLC).":[19],"antitumor":[21,70,143,152],"efficacy":[22,71],"of":[23,72,112,156],"erlotinib":[24,73],"(Tarceva,":[25],"F.":[26],"Hoffmann-La":[27],"Roche,":[28],"Ltd.,":[29],"Basel,":[30],"Switzerland),":[31],"a":[32],"tyrosine-kinase":[34],"inhibitor,":[35],"was":[36,74],"investigated":[37],"in":[38,45,98,145],"relation":[39],"to":[40,57,137],"expression":[44,89,122,131],"five":[46,126,146],"NSCLC":[47,100,147],"xenograft":[48],"models.":[49,101],"MATERIALS":[50],"AND":[51],"METHODS:":[52],"Tumor-bearing":[53],"mice":[54],"were":[55,90],"randomized":[56],"daily":[58],"oral":[59],"erlotinib,":[60],"50":[61],"mg/kg,":[62],"or":[63],"vehicle":[64],"(controls)":[65],"20-50":[67],"days.":[68],"measured":[75],"through":[76],"tumor":[77,80,83,96,106,116,127],"volume,":[78],"serum":[79,105],"markers":[81],"biomarkers.":[84],"Tumor":[85],"analyzed":[91],"immunohistochemically.":[92],"RESULTS:":[93],"Erlotinib":[94,140],"reduced":[95,104],"volume":[97],"three":[99],"It":[102],"also":[103],"marker":[107],"levels":[108],"the":[110,125],"extent":[111],"inhibition":[113],"correlated":[114],"with":[115],"inhibition.":[118],"differed":[123],"between":[124],"models,":[128,148],"suggesting":[129,149],"that":[130,150],"level":[132],"does":[133],"not":[134],"predict":[135],"response":[136],"treatment.":[138],"CONCLUSION:":[139],"showed":[141],"differing":[142],"activity":[144],"its":[151],"effect":[153],"is":[154],"independent":[155],"overexpression.":[160]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}